SCHEMBL19108682

SCHEMBL19108682

c1ccc(-c2ccc3oc4ccc5ccc6c7ccccc7oc6c5c4c3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.46
▸ PLA2G4A P47712 5/20 0.46
▸ PGR P06401 1/20 0.41
▸ PLA2G10 O15496 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ CASP3 P42574 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ALPI P09923 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ CASP6 P55212 1/20 0.40
▸ MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17299548 0.91 PLA2G2A (0.48) PLA2G2APLA2G4APGRPLA2G10KDM4E
SCHEMBL24341598 0.90 PLA2G2A (0.41) PLA2G2APLA2G4APGRPLA2G10KDM4E
SCHEMBL24342820 0.89 PLA2G2A (0.42) PLA2G2APLA2G4APGRPLA2G10KDM4E
SCHEMBL17807301 0.88 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL17945577 0.87 PLA2G2A (0.42) PLA2G2APLA2G4APGRPLA2G10KDM4E
SCHEMBL24342841 0.86 PLA2G2A (0.44) PLA2G2APLA2G4APGRPLA2G10KDM4E
SCHEMBL24342815 0.86 PLA2G2A (0.40) PLA2G2APLA2G4APGRPLA2G10KDM4E
SCHEMBL17944776 0.86 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL19108609 0.85 AHR (0.37) PLA2G2APLA2G4APGRKDM4EMEN1
SCHEMBL27170318 0.85 PGR (0.43) PLA2G2APLA2G4APGRPLA2G10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 PLA2G2A 4537/4885PLA2G4A 4462/4885PGR 1328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback